Measuring corneal stiffness in glaucoma with Brillouin microscopy
Official title: Development of Robust Corneal Biomechanical Biomarkers for Glaucoma Using Brillouin Microscopy
Run by University of Maryland, Baltimore · NCT06993597 · Data updated 2026-11-12
We will use Brillouin microscopy to see if corneal stiffness differs between adults with normal-tension glaucoma, high-tension glaucoma, and people without glaucoma, and whether stiffness changes after common IOP-lowering eye drops.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | March 2027 |
| Study ends | June 2027 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT06993597 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with primary open-angle glaucoma—either high-tension (IOP ≥22 mmHg on three visits) or normal-tension (IOP ≤21 mmHg on three visits)—or age-matched controls with normal optic nerves and visual fields, good visual acuity, refractive error within study limits, open angles, and no prior topical glaucoma medication use are ideal candidates.
✕Probably not a fit
Patients with corneal abnormalities, prior ocular surgery or laser, retinal disease affecting RNFL, diabetes, uveitis, prolonged steroid use, neurodegenerative or systemic disorders, unreliable visual fields, or contraindications to beta blockers are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational pilot enrolls adults with primary open-angle glaucoma (high- and normal-tension) and age-matched healthy controls for cross-sectional and longitudinal imaging. Participants undergo non-contact Brillouin microscopy to measure corneal biomechanical properties, with baseline comparisons across the three groups. Glaucoma participants who start prostaglandin analogs or topical beta blockers will have repeat imaging to detect treatment-related changes over time. The study aims to determine whether Brillouin-derived stiffness measures could serve as biomarkers for glaucoma susceptibility or progression and to evaluate the technique's feasibility in clinical care.
Why it matters
Potential benefit: If successful, Brillouin-derived corneal stiffness measures could help identify patients at higher risk of glaucoma progression and guide more personalized treatment decisions.
How similar studies have gone: Brillouin microscopy is a relatively new, non-contact technique with limited clinical data; small prior studies suggest a link between corneal biomechanics and glaucoma risk, so this approach is novel but builds on early evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Age 18 years or older Diagnosis of primary open angle glaucoma (POAG) or no history of glaucoma (for controls) Open angle on gonioscopy (Shaffer grade 3 or 4) Best-corrected visual acuity of 20/25 or better Refractive error between +3.00 and -5.00 diopters No prior use of topical glaucoma medications Diagnosis of: High Tension Glaucoma (IOP ≥ 22 mmHg on 3 visits) Normal Tension Glaucoma (IOP ≤ 21 mmHg on 3 visits) OR age-matched control with normal optic nerve and visual fields Exclusion Criteria: Corneal abnormalities or conditions interfering with Brillouin or applanation tonometry Retinal diseases affecting RNFL (e.g., macular traction) History of ocular surgery or laser Diagnosis of diabetes History of uveitis History of prolonged steroid use Neurodegenerative or systemic diseases (e.g., multiple sclerosis, Alzheimer's, Parkinson's, schizophrenia) Unreliable visual fields Contraindications to beta blockers (e.g., bradycardia, severe pulmonary disease) Moderate to severe glaucoma (per Hodapp-Anderson-Parrish criteria) History of contact lens use Low blood pressure
Where it's running
-
University of Maryland School of Medicine
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Osamah Saeedi, MD — University of Maryland, Baltimore
- Study coordinator: Osamah Saeedi, MD
- Email: osaeedi@som.umaryland.edu
- Phone: 16672141232
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.